Market Place
Sourcing Support
Pfizer to press pause on large M&A deals, CEO says
11 Jun 2024 //
FIERCE PHARMA
Pfizer to end licence deal with Syros for blood disorder therapies
22 Jul 2023 //
BUSINESS TIMES
Global Blood Therapeutics` Oxbryta (voxelotor) Receives Approval in Europe
13 Jun 2023 //
EMA
GBT and Sickle Cell Disease Association of America to Host 11th
08 Sep 2022 //
GLOBENEWSWIRE
J&J lost to Pfizer in $5.4B GBT bidding war: Bloomberg
24 Aug 2022 //
FIERCEPHARMA
How Pfizer became interested in GBT and reached the $5.4B buy
23 Aug 2022 //
FIERCEPHARMA
Lilly criticizes Indiana abortion law, indicating it may look elsewhere to hire
09 Aug 2022 //
BIOPHARMADIVE
Pfizer eyeing $5B play for Global Blood Therapeutics: WSJ
06 Aug 2022 //
FIERCEPHARMA
GBT Announces New Employment Inducement Grants
04 Aug 2022 //
PRESS RELEASE
GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
03 Aug 2022 //
GLOBENEWSWIRE
GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
29 Jul 2022 //
GLOBENEWSWIRE
MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta
26 Jul 2022 //
PHARMATIMES
MHRA Grants MAA for GBT`s Oxbryta (voxelotor) for Use in Hemolytic Anemia in SCD
26 Jul 2022 //
GLOBENEWSWIRE
GBT Announces New Employment Inducement Grants
07 Jul 2022 //
GLOBENEWSWIRE
GBT Initiates PII/III Trial of GBT601 in Sickle Cell Disease
29 Jun 2022 //
GLOBENEWSWIRE
GBT Announces Participation in Upcoming Investor Conferences
05 May 2022 //
GLOBENEWSWIRE
GBT Announces New Employment Inducement Grants
05 May 2022 //
GLOBENEWSWIRE
GBT Launches Inaugural Environmental, Social and Governance (ESG) Report
28 Apr 2022 //
GLOBENEWSWIRE
GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022
27 Apr 2022 //
GLOBENEWSWIRE
GBT Announces New Employment Inducement Grants
07 Apr 2022 //
GLOBENEWSWIRE
GBT`s Biologic Oxbryta (Voxelotor) Receives Approval in Europe
17 Mar 2022 //
EMA
GBT Announces New Employment Inducement Grants
03 Feb 2022 //
GLOBENEWSWIRE
EAMS Scientific Opinion Awarded to Voxelotor for Haemolytic Anaemia Due to SCD
27 Jan 2022 //
GLOBENEWSWIRE
Positive CHMP opinion for sickle cell disease anaemia tablet
20 Dec 2021 //
PHARMAFILE
U.S. FDA Approves sNDA for Expanded Indication of Oxbryta®
17 Dec 2021 //
IRGBT
GBT’s Oxbryta® (voxelotor) Receives Positive CHMP Opinion
17 Dec 2021 //
GLOBENEWSWIRE
U.S. FDA Approves Supplemental New Drug Application for Expanded of Oxbryta
17 Dec 2021 //
GLOBENEWSWIRE
Global Blood sickle-cell drug improves hemoglobin response in small study
13 Dec 2021 //
STATNEWS
GBT Announces Six Data Presentations on Sickle Cell Disease at ASH 2021
04 Nov 2021 //
GLOBENEWSWIRE
GBT sickle cell campaign agency launches pharma comms division
20 Oct 2021 //
FIERCEPHARMA
GBT Announces Participation at the Cantor Global Healthcare Conference
20 Sep 2021 //
GLOBENEWSWIRE
GBT Establishes The GBT Foundation to Improve the Health and Well-being
14 Sep 2021 //
GLOBENEWSWIRE
GBT & SCDAA to Host 10th Annual SCD Therapeutics Conference
08 Sep 2021 //
GLOBENEWSWIRE
U.S. FDA to review use of GBT`s blood disorder therapy in children
07 Sep 2021 //
REUTERS
FDA Accepts for Priority Review sNDA for Oxbryta for SCD in Children 4 to 11
07 Sep 2021 //
GLOBENEWSWIRE
GBT debuts first DTC campaign for sickle cell med Oxbryta
30 Jul 2021 //
FIERCEPHARMA
GBT Awards $450K in ACCEL Grants to Improve Access to Care in SCD
15 Jun 2021 //
GLOBENEWSWIRE
GBT’s Voxelotor to Receive PIM Designation in the UK
14 Jun 2021 //
GLOBENEWSWIRE
GBT Announces Upcoming Data Presentations at EHA 2021 Virtual Congress
12 May 2021 //
GLOBENEWSWIRE
GBT Appoints Alexis A. Thompson to Board of Directors
18 Mar 2021 //
GLOBENEWSWIRE
Global Blood takes on more sickle cell drugs through Sanofi deal
17 Mar 2021 //
BIOPHARMADIVE
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta (voxelotor)
08 Sep 2020 //
GLOBENEWS WIRE
GBT Announces Plans to Seek Regulatory Approval for Oxbryta®
24 Jun 2020 //
GLOBENEWSWIRE
GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor)
08 Jun 2020 //
GLOBENEWSWIRE
Two CEOs, two different therapies, and a fight to chase down sickle cell
17 Jan 2020 //
END PTS
Research pact between Syros Pharma, Global Blood seeks new drugs
19 Dec 2019 //
STATNEWS
Global Blood taps Syros for its next act in blood disorders
18 Dec 2019 //
BIOPHARMADIVE
Global Blood Therapeutics scores FDA nod for Oxbryta
27 Nov 2019 //
FIERCE PHARMA
GBT Announces USFDA of NDA & Priority Review for Voxelotor Sickle Cell Disease
05 Sep 2019 //
GLOBENEWSWIRE
Global Blood Therapeutics buoyed by good news from FDA; Cigna to help
05 Sep 2019 //
ENDPTS
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
27 Jun 2019 //
BIOSPACE
GBT sickle cell trial hits endpoint ahead of NDA filing
18 Jun 2019 //
FIERCE BIOTECH
GBT Continues To Build Case For Successful Commercialization
14 Jan 2019 //
SEEKING ALPHA
Global Blood Therapeutics Gets A Quick Advance Surprise By The FDA
06 Dec 2018 //
SEEKING ALPHA
